Inhibition of precursor B cell malignancy progression by toll-like receptor ligand-induced immune responses

Podobne zapisy

• Differential Depletion of Bone Marrow Resident B-ALL after Systemic Administration of Endosomal TLR Agonists
  od: Jo, Sumin, i wsp.
  Wydane: (2020)
• Long-term protection from syngeneic acute lymphoblastic leukemia by CpG ODN-mediated stimulation of innate and adaptive immune responses
  od: Seif, Alix E., i wsp.
  Wydane: (2009)
• Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease
  od: Brown, Valerie I., i wsp.
  Wydane: (2008)
• Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modeling
  od: Barrett, David M., i wsp.
  Wydane: (2011)
• Deciphering the DNA damage histone code: Comment on: Xie A, et al. Cell Cycle 2010; 9:3602–10
  od: DeMicco, Amy, i wsp.
  Wydane: (2010)